These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31387805)

  • 41. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.
    Sulzer MA; Leers MP; van Noord JA; Bollen EC; Theunissen PH
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1319-23. PubMed ID: 9563756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
    Wang L; Li X; Li Y; Xue YW
    Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between expression of cell adhesion molecules CD₄₄ v6 and E-cadherin and lymphatic metastasis in non- small cell lung cancer.
    Su CY; Li YS; Han Y; Zhou SJ; Liu ZD
    Asian Pac J Cancer Prev; 2014; 15(5):2221-4. PubMed ID: 24716905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.
    Vicent S; López-Picazo JM; Toledo G; Lozano MD; Torre W; Garcia-Corchón C; Quero C; Soria JC; Martín-Algarra S; Manzano RG; Montuenga LM
    Br J Cancer; 2004 Mar; 90(5):1047-52. PubMed ID: 14997206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlations of S100A4 protein expression to invasion and metastasis of non-small cell lung cancer].
    Chen XL; Zhang WG; Chen XY; Sun ZM; Liu SH
    Ai Zheng; 2006 Sep; 25(9):1134-7. PubMed ID: 16965657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-17 promoted metastasis of non-small-cell lung cancer cells.
    Li Q; Han Y; Fei G; Guo Z; Ren T; Liu Z
    Immunol Lett; 2012 Dec; 148(2):144-50. PubMed ID: 23089548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].
    Weng MX; Wu CH; Yang XP
    Ai Zheng; 2008 Feb; 27(2):191-5. PubMed ID: 18279620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4+, IL17 and Foxp3 expression in different pTNM stages of operable non-small cell lung cancer and effects on disease prognosis.
    Zhang GQ; Han F; Fang XZ; Ma XM
    Asian Pac J Cancer Prev; 2012; 13(8):3955-60. PubMed ID: 23098499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis.
    Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H
    Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.
    Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z
    Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancer.
    Chen P; Yu J; Knecht J; Chen Q
    Cancer Epidemiol; 2013 Apr; 37(2):166-71. PubMed ID: 23312889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues.
    Zhang XL; Dang YW; Li P; Rong MH; Hou XX; Luo DZ; Chen G
    Asian Pac J Cancer Prev; 2014; 15(24):10591-6. PubMed ID: 25605144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer.
    Fan C; Miao Y; Zhang X; Liu D; Jiang G; Lin X; Han Q; Luan L; Xu Z; Wang E
    BMC Cancer; 2014 Sep; 14():704. PubMed ID: 25253020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
    World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic and prognostic significance of E-cadherin and Ki-67 expression in non-small cell lung cancer patients.
    He LY; Zhang H; Wang ZK; Zhang HZ
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3812-3817. PubMed ID: 27735037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.